Predictors of nonalcoholic steatohepatitis in japanese patients: Thioredoxin and NASH

NASH and Nutritional Therapy

Volumn , Issue , 2005, Pages 64-72

  Okanoue, Takeshi ^a   Yamauchi, Norihito ^a   Furutani, Masanori ^a   Hirohama, Akihisa ^a   Sumida, Yoshio ^a   Nakashima, Toshiaki ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Insulin resistance; Nonalcoholic steatohepatitis; Oxidative stress; Serum ferritin; Thioredoxin

Indexed keywords

EID: 69249207377     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/4-431-27172-4_5     Document Type: Chapter

References (28)

1. Sanyal AJ (2002) Technical review on nonalcoholic fatty liver disease. Gastroenterology 123: 1705-1725
2. Younossi ZM, Diehl AM, Ong JP (2002) Nonalcoholic fatty liver disease: an agenda for clinical research. Hepatology 35: 746-752
3. Powell EE, Cooksley WGE, Hanson R, Searle J (1990) The natural history of nonalcoholic steatohepatitis: a follow-up study of 42 patients for up to 21 years. Hepatology 11: 74-80
4. Day CP, James OFW (1998) Steatohepatitis: a tale of two 'hits'? Gastroenterology 114: 842-845
5. James O, Day C (1999) Non-Alcoholic steatohepatitis: another disease of affluence. Lancet 353: 1634-1636
6. George DK, Goldwurm S,Macdonald GA (1998) Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 114: 311-318
7. Hirota K,Matsui M, Iwata S (1997) AP-1 transcription activity is regulated by a direct association between thioredoxin and Ref-1. Proc Natl Acad Sci USA 94: 3633-3638
8. Nakamura H,Nakamura K,Yodoi J (1997) Redox regulation of cellular activation.Annu Rev Immunol 15: 351-369
9. Linnen J,Wages J Jr., Zhang-Keck ZY (1996) Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 271: 505-508
10. Simons JN, Leary TP, Dawson GJ (1995) Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1: 564-569
11. Kiyosawa K (1997) Non-Alcoholic steatohepatitis and GB virus-C/hepatitis G virus infection: is there a causal relationship? Intern Med 36: 236-237
12. Nishizawa T, Okamoto H, Konishi K (1997) A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun 241: 92-97
13. Tokita H,Murai S, Kamitsukasa H (2001) Influence of TT virus on the histopathological features of nonalcoholic fatty liver disease. Hepatol Res 19: 197-211
14. Primi D, Fiordalisi G, Mantero JL, Identification of SENV genotypes. International patent number WO0028039 (international application published under the patent cooperation treaty). http://ep.espacenet.com
15. Tanaka Y, Primi D, Wang RYH (2001) Genomic and molecular evolutionary analysis of a newly identified infectious agent (SEN virus) and its relationship to the TT virus family. J Infect Dis 183: 359-367
16. Umemura T, Yeo AET, Sottini A (2001) SEN virus infection and its relationship to transfusion-Associated hepatitis. Hepatology 33: 1303-1311
17. Brunt EM, Janney CG, DiBisceglie AM (2000) Nonalcoholic steatohepatitis: a proposal for grading and staging the histologic lesions. Am J Gastroenterol 94: 2467-2474
18. MacSween RNM, Anthony PP, Sheuer PJ (1987) Pathology of the liver. Churchill Livingstone, Edinburgh, p 185
19. Tan D, Matsumoto A, Conry-Cantilena C (1999) Analysis of hepatitis G virus (HGV) RNA, antibody to HGV envelope protein, and risk factors for blood donors coinfected with HGV and hepatitis C virus. J Infect Dis 179: 1055-1061
20. Kazemi-Shirazi L, Datz C,Maier-Dobersberger T (1998) The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C. Gastroenterology 116: 127-134
21. Matteoni CA,Younossi ZM, Gramlich T (1999) Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116: 1413-1419
22. Bacon BR, Farahvash MJ, Janney CG (1994) Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 107: 1103-1109
23. Sumida Y,Nakashima T,Yoh T (2003) Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease. J Hepatol 38: 32-38
24. Angulo P, Keach J, Batts K (1999) Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 30: 1356-1362
25. Mendler M,Turlin B,Moirand R (1999) Insulin resistance-Associated hepatic iron overload. Gastroenterology 117: 1155-1163
26. Sohda T,Yanai J, Soejima H (1999) Frequencies in the Japanese population of HFE gene mutations. Biochem Genet 37: 63-68
27. Loguercio C, Girolamo V, Sio IF (2001) Non-Alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects. J Hepatol 35: 568-574
28. Powell EE, Kroon PA (1992) Liver, lipoproteins and disease: II. Clinical relevance of disordered cholesterol metabolism in liver disease. J Gastroenterol Hepatol 7: 225-231